Global Information
회사소개 | 문의 | 비교리스트

세계의 나노입자 약물 전달 시스템 시장 : 규모, 현황, 예측(2021-2027년)

Global Nanoparticle Drug Delivery Systems Market Size, Status and Forecast 2021-2027 (Customized Version)

리서치사 QYResearch
발행일 2021년 05월 상품코드 1006775
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,400 ₩ 6,361,000 PDF (Single User License)
US $ 6,600 ₩ 9,542,000 PDF (Multi User License)
US $ 8,800 ₩ 12,723,000 PDF (Enterprise User License)


세계의 나노입자 약물 전달 시스템 시장 : 규모, 현황, 예측(2021-2027년) Global Nanoparticle Drug Delivery Systems Market Size, Status and Forecast 2021-2027 (Customized Version)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 나노입자 약물 전달 시스템 시장 규모는 2020년에는 40억 8,900만 달러, 2027년까지 81억 300만 달러에 달할 전망입니다.

또한 2021-2027년간 연평균 복합 성장률(CAGR)은 10%를 나타낼 것으로 예측됩니다.

세계의 나노입자 약물 전달 시스템 시장을 분석했으며, 업계의 기본 구조와 배경 및 최신 상황, 전체적인 시장 동향 전망(2016-2027년), 종류별·용도별·지역별 상세 동향, 기업간 경쟁 구도(시장 점유율 구조), 주요 기업 개요와 실적 동향 등의 정보를 전해드립니다.

목차

제1장 분석 개요

  • 분석 범위
  • 종류별 시장 분석
    • 시장 규모·성장률 : 종류별(2016년/2021년/2027년)
    • 리포솜 제제
    • 지질나노입자 제제
  • 용도별 시장
    • 시장 점유율 : 용도별(2016년/2021년/2027년)
    • 병원
    • 소매 약국
  • 분석 대상
  • 분석 기간

제2장 세계 시장 성장 동향

  • 세계의 나노입자 약물 전달 시스템 시장 전망(2016-2027년)
  • 지역별 성장 동향
    • 시장 규모 : 지역별(2016년/2021년/2027년)
    • 시장 규모, 실적 : 지역별(2016-2021년)
    • 시장 규모, 예측 : 지역별(2022-2027년)
  • 나노입자 약물 전달 시스템 업계 시장 역학
    • 나노입자 약물 전달 시스템 시장 동향
    • 나노입자 약물 전달 시스템 시장 성장 촉진요인
    • 나노입자 약물 전달 시스템 시장이 해결해야 할 과제
    • 나노입자 약물 전달 시스템 시장 성장 억제요인

제3장 주요 기업간 경쟁 구도

  • 기업별 매출 동향
    • 시장 매출 : 기업별(2019-2021년)
    • 시장 매출 점유율 : 기업별(2019-2021년)
  • 시장 점유율 : 기업 유형별(Tier 1, Tier 2, Tier 3)
  • 분석 대상 기업 : 매출 순위(나노입자 약물 전달 시스템 관련)
  • 세계의 나노입자 약물 전달 시스템 시장 집중도
    • 시장 집중도(주요 5개사, HHI 지수)
    • 주요 5개사의 시장 매출(2020년)
    • 주요 10개사의 시장 매출(2020년)
  • 주요 기업의 본사 소재지 및 판매 지역
  • 주요 기업의 주력 제품/솔루션/서비스
  • 주요 기업의 창립년도
  • 인수합병(M&A)/사업 확장 계획
  • 주요 지질 재료 공급업체

제4장 나노입자 약물 전달 시스템 시장 : 종류별 상세 데이터

  • 시장 규모, 실적 : 종류별(2016-2021년)
  • 시장 규모, 예측 : 종류별(2022-2027년)

제5장 나노입자 약물 전달 시스템 시장 : 용도별 상세 데이터

  • 시장 규모, 실적 : 용도별(2016-2021년)
  • 시장 규모, 예측 : 용도별(2022-2027년)

제6장 북미

  • 북미의 나노입자 약물 전달 시스템 시장 규모(2016-2027년)
  • 종류별 시장 규모
    • 시장 규모, 실적 : 종류별(2016-2021년)
    • 시장 규모, 예측 : 종류별(2022-2027년)
    • 시장 규모 : 종류별(2016-2027년)
  • 용도별 시장 규모
    • 시장 규모, 실적 : 용도별(2016-2021년)
    • 시장 규모, 예측 : 용도별(2022-2027년)
    • 시장 규모 : 용도별(2016-2027년)
  • 국가별 시장 규모
    • 시장 규모, 실적 : 국가별(2016-2021년)
    • 시장 규모, 예측 : 국가별(2022-2027년)
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽

  • 유럽의 나노입자 약물 전달 시스템 시장 규모(2016-2027년)
  • 종류별 시장 규모
  • 용도별 시장 규모
  • 국가별 시장 규모
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 러시아

제8장 아시아태평양

  • 아시아태평양의 나노입자 약물 전달 시스템 시장 규모(2016-2027년)
  • 종류별 시장 규모
  • 용도별 시장 규모
  • 국가별 시장 규모
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주

제9장 남미

  • 남미의 나노입자 약물 전달 시스템 시장 규모(2016-2027년)
  • 종류별 시장 규모
  • 용도별 시장 규모
  • 국가별 시장 규모
    • 브라질

제10장 중동 및 아프리카

  • 중동 및 아프리카의 나노입자 약물 전달 시스템 시장 규모(2016-2027년)
  • 종류별 시장 규모
  • 용도별 시장 규모
  • 국가별 시장 규모
    • 중동
    • 아프리카

제11장 주요 기업 개요

  • Johnson &Johnson
  • Sun Pharmaceutical
  • CSPC
  • Kinyond
  • Teva
  • Fudan-Zhangjiang
  • Zydus Cadila
  • TTY Biopharma
  • Pacira
  • Luye Pharma
  • Leadiant Biosciences
  • Ipsen
  • Sayre Therapeutics
  • Jazz
  • Alnylam
  • Bausch Health
  • Acrotech Biopharma
  • Takeda
  • Chiesi Farmaceutici
  • Gilead Sciences

제12장 애널리스트의 견해/결론

제13장 부록

LSH 21.06.23

List of Tables and Figures

  • Table 1. Global Nanoparticle Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027
  • Table 2. Key Players of Liposomes Drugs
  • Table 3. Key Players of Lipid Nanoparticle Drugs
  • Table 4. Global Nanoparticle Drug Delivery Systems Market Size Growth by Application (US$ Million): 2016 VS 2020 VS 2027
  • Table 5. Global Nanoparticle Drug Delivery Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
  • Table 6. Global Nanoparticle Drug Delivery Systems Market Size by Regions (2016-2021) & (US$ Million)
  • Table 7. Global Nanoparticle Drug Delivery Systems Market Share by Regions (2016-2021)
  • Table 8. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million)
  • Table 9. Global Nanoparticle Drug Delivery Systems Market Share by Regions (2022-2027)
  • Table 10. Nanoparticle Drug Delivery Systems Market Drivers
  • Table 11. Nanoparticle Drug Delivery Systems Market Challenges
  • Table 12. Global Nanoparticle Drug Delivery Systems Revenue by Players (2019-2021) & (US$ Million)
  • Table 13. Global Nanoparticle Drug Delivery Systems Market Share by Players (2019-2021)
  • Table 14. Global Top Nanoparticle Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticle Drug Delivery Systems as of 2020)
  • Table 15. Ranking of Global Top Nanoparticle Drug Delivery Systems Companies by Revenue (US$ Million) in 2020
  • Table 16. Global 5 Largest Players Market Share by Nanoparticle Drug Delivery Systems Revenue (CR5 and HHI) & (2019-2021)
  • Table 17. Key Players Headquarters and Area Served
  • Table 18. Key Players Nanoparticle Drug Delivery Systems Product Solution and Service
  • Table 19. Founded Date of Nanoparticle Drug Delivery Systems Players
  • Table 20. Mergers & Acquisitions, Expansion Plans
  • Table 21. Global Top Lipid Material Suppliers' Revenue (2019-2021) & (US$ Million)
  • Table 22. Global Top Lipid Material Suppliers' Market Share (2019-2021)
  • Table 23. Global Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million)
  • Table 24. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2016-2021)
  • Table 25. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Type (2022-2027) & (US$ Million)
  • Table 26. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2022-2027)
  • Table 27. Global Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million)
  • Table 28. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Application (2016-2021)
  • Table 29. Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Application (2022-2027) & (US$ Million)
  • Table 30. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Application (2022-2027)
  • Table 31. North America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million)
  • Table 32. North America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
  • Table 33. North America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million)
  • Table 34. North America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
  • Table 35. North America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
  • Table 36. North America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
  • Table 37. Europe Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million)
  • Table 38. Europe Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
  • Table 39. Europe Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million)
  • Table 40. Europe Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
  • Table 41. Europe Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
  • Table 42. Europe Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
  • Table 43. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million)
  • Table 44. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
  • Table 45. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million)
  • Table 46. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
  • Table 47. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2016-2021) & (US$ Million)
  • Table 48. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2022-2027) & (US$ Million)
  • Table 49. South America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million)
  • Table 50. South America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
  • Table 51. South America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million)
  • Table 52. South America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
  • Table 53. South America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
  • Table 54. South America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
  • Table 55. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021) & (US$ Million)
  • Table 56. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million)
  • Table 57. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021) & (US$ Million)
  • Table 58. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million)
  • Table 59. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million)
  • Table 60. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million)
  • Table 61. Johnson & Johnson Company Details
  • Table 62. Johnson & Johnson Business Overview
  • Table 63. Johnson & Johnson Nanoparticle Drug Delivery Systems Product
  • Table 64. Johnson & Johnson Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 65. Johnson & Johnson Recent Development
  • Table 66. Sun Pharmaceutical Company Details
  • Table 67. Sun Pharmaceutical Business Overview
  • Table 68. Sun Pharmaceutical Nanoparticle Drug Delivery Systems Product
  • Table 69. Sun Pharmaceutical Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 70. CSPC Company Details
  • Table 71. CSPC Business Overview
  • Table 72. CSPC Nanoparticle Drug Delivery Systems Product
  • Table 73. CSPC Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 74. Kinyond Company Details
  • Table 75. Kinyond Business Overview
  • Table 76. Kinyond Nanoparticle Drug Delivery Systems Product
  • Table 77. Kinyond Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 78. Teva Company Details
  • Table 79. Teva Business Overview
  • Table 80. Teva Nanoparticle Drug Delivery Systems Product
  • Table 81. Teva Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 82. Teva Recent Development
  • Table 83. Fudan-Zhangjiang Company Details
  • Table 84. Fudan-Zhangjiang Business Overview
  • Table 85. Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Product
  • Table 86. Fudan-Zhangjiang Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 87. Zydus Cadila Company Details
  • Table 88. Zydus Cadila Business Overview
  • Table 89. Zydus Cadila Nanoparticle Drug Delivery Systems Product
  • Table 90. Zydus Cadila Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 91. TTY Biopharma Company Details
  • Table 92. TTY Biopharma Business Overview
  • Table 93. TTY Biopharma Nanoparticle Drug Delivery Systems Product
  • Table 94. TTY Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 95. Pacira Company Details
  • Table 96. Pacira Business Overview
  • Table 97. Pacira Nanoparticle Drug Delivery Systems Product
  • Table 98. Pacira Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 99. Pacira Recent Development
  • Table 100. Luye Pharma Company Details
  • Table 101. Luye Pharma Business Overview
  • Table 102. Luye Pharma Nanoparticle Drug Delivery Systems Product
  • Table 103. Luye Pharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 104. Leadiant Biosciences Company Details
  • Table 105. Leadiant Biosciences Business Overview
  • Table 106. Leadiant Biosciences Nanoparticle Drug Delivery Systems Product
  • Table 107. Leadiant Biosciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 108. Leadiant Biosciences Recent Development
  • Table 109. Ipsen Company Details
  • Table 110. Ipsen Business Overview
  • Table 111. Ipsen Nanoparticle Drug Delivery Systems Product
  • Table 112. Ipsen Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 113. Ipsen Recent Development
  • Table 114. Sayre Therapeutics Company Details
  • Table 115. Sayre Therapeutics Business Overview
  • Table 116. Sayre Therapeutics Nanoparticle Drug Delivery Systems Product
  • Table 117. Sayre Therapeutics Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 118. Sayre Therapeutics Recent Development
  • Table 119. Jazz Company Details
  • Table 120. Jazz Business Overview
  • Table 121. Jazz Nanoparticle Drug Delivery Systems Product
  • Table 122. Jazz Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 123. Jazz Recent Development
  • Table 124. Alnylam Company Details
  • Table 125. Alnylam Business Overview
  • Table 126. Alnylam Nanoparticle Drug Delivery Systems Product
  • Table 127. Alnylam Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 128. Alnylam Recent Development
  • Table 129. Bausch Health Company Details
  • Table 130. Bausch Health Business Overview
  • Table 131. Bausch Health Nanoparticle Drug Delivery Systems Product
  • Table 132. Bausch Health Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 133. Bausch Health Recent Development
  • Table 134. Acrotech Biopharma Company Details
  • Table 135. Acrotech Biopharma Business Overview
  • Table 136. Acrotech Biopharma Nanoparticle Drug Delivery Systems Product
  • Table 137. Acrotech Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 138. Acrotech Biopharma Recent Development
  • Table 139. Takeda Company Details
  • Table 140. Takeda Business Overview
  • Table 141. Takeda Nanoparticle Drug Delivery Systems Product
  • Table 142. Takeda Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 143. Takeda Recent Development
  • Table 144. Chiesi Farmaceutici Company Details
  • Table 145. Chiesi Farmaceutici Business Overview
  • Table 146. Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Product
  • Table 147. Chiesi Farmaceutici Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 148. Gilead Sciences Company Details
  • Table 149. Gilead Sciences Business Overview
  • Table 150. Gilead Sciences Nanoparticle Drug Delivery Systems Product
  • Table 151. Gilead Sciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021) & (US$ Million)
  • Table 152. Gilead Sciences Recent Development
  • Table 153. Research Programs/Design for This Report
  • Table 154. Key Data Information from Secondary Sources
  • Table 155. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Nanoparticle Drug Delivery Systems Market Share by Type: 2020
  • Figure 2. Global Nanoparticle Drug Delivery Systems Market Share by Type: 2027
  • Figure 3. Liposomes Drugs Features
  • Figure 4. Lipid Nanoparticle Drugs Features
  • Figure 5. Hospital Case Studies
  • Figure 6. Retail Pharmacy Case Studies
  • Figure 7. Nanoparticle Drug Delivery Systems Report Years Considered
  • Figure 8. Global Nanoparticle Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2016-2027
  • Figure 9. Global Nanoparticle Drug Delivery Systems Market Size, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 10. Global Nanoparticle Drug Delivery Systems Market Share by Regions: 2020
  • Figure 11. Global Nanoparticle Drug Delivery Systems Market Share by Regions: 2027
  • Figure 12. Global Nanoparticle Drug Delivery Systems Market Share by Regions (2022-2027)
  • Figure 13. Global Nanoparticle Drug Delivery Systems Market Share by Players in 2020
  • Figure 14. The Top 5 Players Market Share by Nanoparticle Drug Delivery Systems Revenue in 2020
  • Figure 15. The Top 10 Players Market Share by Nanoparticle Drug Delivery Systems Revenue in 2020
  • Figure 16. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2016-2021)
  • Figure 17. Global Nanoparticle Drug Delivery Systems Revenue Market Share by Type (2022-2027)
  • Figure 18. North America Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 19. North America Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027)
  • Figure 20. North America Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027)
  • Figure 21. North America Nanoparticle Drug Delivery Systems Market Share by Country (2016-2027)
  • Figure 22. United States Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 23. Canada Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 24. Mexico Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 25. Europe Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 26. Europe Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027)
  • Figure 27. Europe Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027)
  • Figure 28. Europe Nanoparticle Drug Delivery Systems Market Share by Country (2016-2027)
  • Figure 29. Germany Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 30. France Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 31. U.K. Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 32. Italy Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 33. Russia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 34. Asia-Pacific Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 35. Asia-Pacific Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027)
  • Figure 36. Asia-Pacific Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027)
  • Figure 37. Asia-Pacific Nanoparticle Drug Delivery Systems Market Share by Region (2016-2027)
  • Figure 38. China Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 39. Japan Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 40. South Korea Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 41. Southeast Asia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 42. India Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 43. Australia Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 44. South America Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 45. South America Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027)
  • Figure 46. South America Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027)
  • Figure 47. South America Nanoparticle Drug Delivery Systems Market Share by Country 2020
  • Figure 48. Brazil Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 49. Middle East & Africa Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 50. Middle East & Africa Nanoparticle Drug Delivery Systems Market Share by Type (2016-2027)
  • Figure 51. Middle East & Africa Nanoparticle Drug Delivery Systems Market Share by Application (2016-2027)
  • Figure 52. Middle East & Africa Nanoparticle Drug Delivery Systems Market Share by Country 2020
  • Figure 53. Middle East Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 54. Africa Nanoparticle Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed 138

Market Analysis and Insights:

The global Nanoparticle Drug Delivery Systems market size is projected to reach US$ 8103 million by 2027, from US$ 4089 million in 2020, at a CAGR of 10% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanoparticle Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanoparticle Drug Delivery Systems market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanoparticle Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanoparticle Drug Delivery Systems market.

Scope and Market Size:

Nanoparticle Drug Delivery Systems market is segmented by players, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global Nanoparticle Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and By Application in terms of revenue and forecast for the period 2016-2027.

By Company

  • Johnson & Johnson
  • Sun Pharmaceutical
  • CSPC
  • Kinyond
  • Teva
  • Fudan-Zhangjiang
  • Zydus Cadila
  • TTY Biopharma
  • Pacira
  • Luye Pharma
  • Leadiant Biosciences
  • Ipsen
  • Sayre Therapeutics
  • Jazz
  • Alnylam
  • Bausch Health
  • Acrotech Biopharma
  • Takeda
  • Chiesi Farmaceutici
  • Gilead Sciences

Segment by Type

  • Liposomes Drugs
  • Lipid Nanoparticle Drugs

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Other

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Rest of South America
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Nanoparticle Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Liposomes Drugs
    • 1.2.3 Lipid Nanoparticle Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Nanoparticle Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Retail Pharmacy
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 GLOBAL GROWTH TRENDS

  • 2.1 Global Nanoparticle Drug Delivery Systems Market Perspective (2016-2027)
  • 2.2 Nanoparticle Drug Delivery Systems Growth Trends by Regions
    • 2.2.1 Nanoparticle Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Nanoparticle Drug Delivery Systems Historic Market Size by Regions (2016-2021)
    • 2.2.3 Nanoparticle Drug Delivery Systems Forecasted Market Size by Regions (2022-2027)
  • 2.3 Nanoparticle Drug Delivery Systems Industry Dynamic
    • 2.3.1 Nanoparticle Drug Delivery Systems Market Trends
    • 2.3.2 Nanoparticle Drug Delivery Systems Market Drivers
    • 2.3.3 Nanoparticle Drug Delivery Systems Market Challenges
    • 2.3.4 Nanoparticle Drug Delivery Systems Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 Global Top Nanoparticle Drug Delivery Systems Players by Revenue
    • 3.1.1 Global Top Nanoparticle Drug Delivery Systems Players by Revenue (2019-2021)
    • 3.1.2 Global Nanoparticle Drug Delivery Systems Revenue Market Share by Players (2019-2021)
  • 3.2 Global Nanoparticle Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Nanoparticle Drug Delivery Systems Revenue
  • 3.4 Global Nanoparticle Drug Delivery Systems Market Concentration Ratio
    • 3.4.1 Global Nanoparticle Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 5 Companies by Nanoparticle Drug Delivery Systems Revenue in 2020
    • 3.4.3 Global Top 10 Companies by Nanoparticle Drug Delivery Systems Revenue in 2020
  • 3.5 Nanoparticle Drug Delivery Systems Key Players Head office and Area Served
  • 3.6 Key Players Nanoparticle Drug Delivery Systems Product Solution and Service
  • 3.7 Founded Date of Nanoparticle Drug Delivery Systems Players
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 3.9 Top Lipid Material Suppliers

4 NANOPARTICLE DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY TYPE

  • 4.1 Global Nanoparticle Drug Delivery Systems Historic Market Size by Type (2016-2021)
  • 4.2 Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Type (2022-2027)

5 NANOPARTICLE DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY APPLICATION

  • 5.1 Global Nanoparticle Drug Delivery Systems Historic Market Size by Application (2016-2021)
  • 5.2 Global Nanoparticle Drug Delivery Systems Forecasted Market Size by Application (2022-2027)

6 NORTH AMERICA

  • 6.1 North America Nanoparticle Drug Delivery Systems Market Size (2016-2027)
  • 6.2 North America Nanoparticle Drug Delivery Systems Market Size by Type
    • 6.2.1 North America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021)
    • 6.2.2 North America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027)
    • 6.2.3 North America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027)
  • 6.3 North America Nanoparticle Drug Delivery Systems Market Size by Application
    • 6.3.1 North America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021)
    • 6.3.2 North America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027)
    • 6.3.3 North America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027)
  • 6.4 North America Nanoparticle Drug Delivery Systems Market Size by Country
    • 6.4.1 North America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021)
    • 6.4.2 North America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada
    • 6.4.5 Mexico

7 EUROPE

  • 7.1 Europe Nanoparticle Drug Delivery Systems Market Size (2016-2027)
  • 7.2 Europe Nanoparticle Drug Delivery Systems Market Size by Type
    • 7.2.1 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021)
    • 7.2.2 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027)
    • 7.2.3 Europe Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027)
  • 7.3 Europe Nanoparticle Drug Delivery Systems Market Size by Application
    • 7.3.1 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021)
    • 7.3.2 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027)
    • 7.3.3 Europe Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027)
  • 7.4 Europe Nanoparticle Drug Delivery Systems Market Size by Country
    • 7.4.1 Europe Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021)
    • 7.4.2 Europe Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size (2016-2027)
  • 8.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type
    • 8.2.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application
    • 8.3.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region
    • 8.4.1 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 SOUTH AMERICA

  • 9.1 South America Nanoparticle Drug Delivery Systems Market Size (2016-2027)
  • 9.2 South America Nanoparticle Drug Delivery Systems Market Size by Type
    • 9.2.1 South America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021)
    • 9.2.2 South America Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027)
    • 9.2.3 South America Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027)
  • 9.3 South America Nanoparticle Drug Delivery Systems Market Size by Application
    • 9.3.1 South America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021)
    • 9.3.2 South America Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027)
    • 9.3.3 South America Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027)
  • 9.4 South America Nanoparticle Drug Delivery Systems Market Size by Country
    • 9.4.1 South America Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021)
    • 9.4.2 South America Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027)
    • 9.4.3 Brazil

10 MIDDLE EAST & AFRICA

  • 10.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size (2016-2027)
  • 10.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type
    • 10.2.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application
    • 10.3.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country
    • 10.4.1 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country (2022-2027)
    • 10.4.3 Middle East
    • 10.4.4 Africa

11 KEY PLAYERS PROFILES

  • 11.1 Johnson & Johnson
    • 11.1.1 Johnson & Johnson Company Details
    • 11.1.2 Johnson & Johnson Business Overview
    • 11.1.3 Johnson & Johnson Nanoparticle Drug Delivery Systems Introduction
    • 11.1.4 Johnson & Johnson Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.1.5 Johnson & Johnson Recent Development
  • 11.2 Sun Pharmaceutical
    • 11.2.1 Sun Pharmaceutical Company Details
    • 11.2.2 Sun Pharmaceutical Business Overview
    • 11.2.3 Sun Pharmaceutical Nanoparticle Drug Delivery Systems Introduction
    • 11.2.4 Sun Pharmaceutical Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
  • 11.3 CSPC
    • 11.3.1 CSPC Company Details
    • 11.3.2 CSPC Business Overview
    • 11.3.3 CSPC Nanoparticle Drug Delivery Systems Introduction
    • 11.3.4 CSPC Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
  • 11.4 Kinyond
    • 11.4.1 Kinyond Company Details
    • 11.4.2 Kinyond Business Overview
    • 11.4.3 Kinyond Nanoparticle Drug Delivery Systems Introduction
    • 11.4.4 Kinyond Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
  • 11.5 Teva
    • 11.5.1 Teva Company Details
    • 11.5.2 Teva Business Overview
    • 11.5.3 Teva Nanoparticle Drug Delivery Systems Introduction
    • 11.5.4 Teva Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.5.5 Teva Recent Development
  • 11.6 Fudan-Zhangjiang
    • 11.6.1 Fudan-Zhangjiang Company Details
    • 11.6.2 Fudan-Zhangjiang Business Overview
    • 11.6.3 Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Introduction
    • 11.6.4 Fudan-Zhangjiang Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
  • 11.7 Zydus Cadila
    • 11.7.1 Zydus Cadila Company Details
    • 11.7.2 Zydus Cadila Business Overview
    • 11.7.3 Zydus Cadila Nanoparticle Drug Delivery Systems Introduction
    • 11.7.4 Zydus Cadila Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
  • 11.8 TTY Biopharma
    • 11.8.1 TTY Biopharma Company Details
    • 11.8.2 TTY Biopharma Business Overview
    • 11.8.3 TTY Biopharma Nanoparticle Drug Delivery Systems Introduction
    • 11.8.4 TTY Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
  • 11.9 Pacira
    • 11.9.1 Pacira Company Details
    • 11.9.2 Pacira Business Overview
    • 11.9.3 Pacira Nanoparticle Drug Delivery Systems Introduction
    • 11.9.4 Pacira Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.9.5 Pacira Recent Development
  • 11.10 Luye Pharma
    • 11.10.1 Luye Pharma Company Details
    • 11.10.2 Luye Pharma Business Overview
    • 11.10.3 Luye Pharma Nanoparticle Drug Delivery Systems Introduction
    • 11.10.4 Luye Pharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
  • 11.11 Leadiant Biosciences
    • 11.11.1 Leadiant Biosciences Company Details
    • 11.11.2 Leadiant Biosciences Business Overview
    • 11.11.3 Leadiant Biosciences Nanoparticle Drug Delivery Systems Introduction
    • 11.11.4 Leadiant Biosciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.11.5 Leadiant Biosciences Recent Development
  • 11.12 Ipsen
    • 11.12.1 Ipsen Company Details
    • 11.12.2 Ipsen Business Overview
    • 11.12.3 Ipsen Nanoparticle Drug Delivery Systems Introduction
    • 11.12.4 Ipsen Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.12.5 Ipsen Recent Development
  • 11.13 Sayre Therapeutics
    • 11.13.1 Sayre Therapeutics Company Details
    • 11.13.2 Sayre Therapeutics Business Overview
    • 11.13.3 Sayre Therapeutics Nanoparticle Drug Delivery Systems Introduction
    • 11.13.4 Sayre Therapeutics Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.13.5 Sayre Therapeutics Recent Development
  • 11.14 Jazz
    • 11.14.1 Jazz Company Details
    • 11.14.2 Jazz Business Overview
    • 11.14.3 Jazz Nanoparticle Drug Delivery Systems Introduction
    • 11.14.4 Jazz Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.14.5 Jazz Recent Development
  • 11.15 Alnylam
    • 11.15.1 Alnylam Company Details
    • 11.15.2 Alnylam Business Overview
    • 11.15.3 Alnylam Nanoparticle Drug Delivery Systems Introduction
    • 11.15.4 Alnylam Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.15.5 Alnylam Recent Development
  • 11.16 Bausch Health
    • 11.16.1 Bausch Health Company Details
    • 11.16.2 Bausch Health Business Overview
    • 11.16.3 Bausch Health Nanoparticle Drug Delivery Systems Introduction
    • 11.16.4 Bausch Health Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.16.5 Bausch Health Recent Development
  • 11.17 Acrotech Biopharma
    • 11.17.1 Acrotech Biopharma Company Details
    • 11.17.2 Acrotech Biopharma Business Overview
    • 11.17.3 Acrotech Biopharma Nanoparticle Drug Delivery Systems Introduction
    • 11.17.4 Acrotech Biopharma Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.17.5 Acrotech Biopharma Recent Development
  • 11.18 Takeda
    • 11.18.1 Takeda Company Details
    • 11.18.2 Takeda Business Overview
    • 11.18.3 Takeda Nanoparticle Drug Delivery Systems Introduction
    • 11.18.4 Takeda Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.18.5 Takeda Recent Development
  • 11.19 Chiesi Farmaceutici
    • 11.19.1 Chiesi Farmaceutici Company Details
    • 11.19.2 Chiesi Farmaceutici Business Overview
    • 11.19.3 Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Introduction
    • 11.19.4 Chiesi Farmaceutici Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
  • 11.20 Gilead Sciences
    • 11.20.1 Gilead Sciences Company Details
    • 11.20.2 Gilead Sciences Business Overview
    • 11.20.3 Gilead Sciences Nanoparticle Drug Delivery Systems Introduction
    • 11.20.4 Gilead Sciences Revenue in Nanoparticle Drug Delivery Systems Business (2019-2021)
    • 11.20.5 Gilead Sciences Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details
Back to Top
전화 문의
F A Q